查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595115

骨关节炎治疗药物市场：依解剖结构、药物类型、给药途径、采购模式、通路 - 2025-2030 年全球预测

Osteoarthritis Therapeutics Market by Anatomy, Drug Type, Route of Administration, Purchasing Pattern, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年骨关节炎药物市值为79亿美元，预计2024年将达到86.9亿美元，复合年增长率为10.39%，预计到2030年将达到157.8亿美元。

骨关节炎药物是指旨在减轻骨关节炎症状并减缓其进展的治疗方法，骨关节炎是一种以软骨破坏为特征的退化性关节疾病。这些包括但不限于非类固醇抗发炎药、皮质类固醇、止痛药、生物製药等药物，以及基因疗法和干细胞疗法等新治疗方法。由于人口老化、肥胖率增加和生活方式的改变，全球骨关节炎盛行率不断上升，推动了对这些治疗方法的需求。这些治疗旨在减轻疼痛和发炎并改善关节功能，主要用于受影响个体的诊所、医院和家庭保健。市场成长受到技术进步、研发投资增加以及早期復健意识提高的影响。此外，联合治疗和微创手术的发展也带来了巨大的机会。公司可以透过投资创新技术并透过策略联盟和收购扩大产品系列来增加资本。然而，高昂的治疗成本、严格的监管要求和潜在的副作用限制了市场的扩张。创新和研究应着重于开发具有成本效益、患者友善且副作用较少的标靶治疗。在药物发现中利用人工智慧和机器学习并开发针对个别患者情况的个人化医疗可以提供竞争优势。市场格局是动态的，其特征是快速发展和需要不断适应的竞争格局。投资先进研究以了解疾病机制和改善输送系统的公司可能会成功。虽然市场前景广阔，但必须克服监管挑战，以确保能够负担得起更广泛的患者群体，并促进骨关节炎管理的更广泛的获取和教育，这凸显了与政府机构和医疗机构合作的必要性。

主要市场统计
基准年[2023] 79亿美元
预测年份 [2024] 86.9亿美元
预测年份 [2030] 157.8亿美元
复合年增长率（%） 10.39%

市场动态：揭示快速发展的骨关节炎药物市场的关键市场洞察

供需的动态交互作用正在改变骨关节炎药物市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球骨关节炎盛行率不断上升
    • 微创手术的潜在需求
    • 随着世界各地运动伤害的增加，老年人口也在增加。
  • 市场限制因素
    • 对 NSAID 副作用的担忧
  • 市场机会
    • 治疗骨关节炎的新药物疗法
    • 骨关节炎领域的持续研究与开发
    • 政府加强对骨关节炎治疗的支持
    • 新兴国家人均医疗费用增加
  • 市场挑战
    • 非药物疼痛管理疗法的快速传播

波特五力：驾驭骨关节炎药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对骨关节炎药物市场的影响

外部宏观环境因素在塑造骨关节炎治疗药物市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解骨关节炎治疗药物市场的竞争状况

对骨关节炎治疗药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵骨关节炎药物市场供应商的绩效评估

FPNV定位矩阵是评估骨关节炎药物市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘骨关节炎药物市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对骨关节炎治疗药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地的骨关节炎盛行率正在上升
      • 微创手术的潜在需求
      • 全球人口老化加剧和运动伤害数量增加
    • 抑制因素
      • 对 NSAID 副作用的担忧
    • 机会
      • 治疗方法骨关节炎的新药物
      • 在骨关节炎领域持续研究和开发
      • 加强政府对骨关节炎治疗的支持
      • 新兴国家人均医疗费用上升
    • 任务
      • 快速引入非药物疼痛管理疗法
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章骨关节炎治疗药物市场剖析

  • 手骨关节炎
  • 髋骨关节炎
  • 膝骨关节炎
  • 小关节骨关节炎

第七章依药物类型分類的骨关节炎治疗市场

  • 止痛药
    • 乙酰胺酚
    • Duloxetine
  • 皮质类固醇
  • 非类固醇消炎剂
    • 阿斯匹灵
    • 双氯芬酸钠
    • Ibuprofen
    • 萘普生
  • 关节内粘稠补充疗法剂

第八章骨关节炎治疗药物市场：依给药途径

  • 口服给药
  • 肠外给药
  • 局部途径

第九章骨关节炎治疗药物市场（依购买模式）

  • 非处方药
  • 处方药

第10章骨关节炎治疗药物市场：按分销管道

  • 医院药房
  • 网路药房
  • 零售药房

第十一章北美和南美的骨关节炎治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太骨关节炎治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲骨关节炎治疗药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Almatica Pharma LLC
  • Anika Therapeutics, Inc.
  • Assertio Therapeutics, Inc.
  • Atnahs Pharma UK Limited
  • Bayer AG
  • Bioventus
  • Eli Lilly and Company
  • Ferring BV
  • Fidia Farmaceutici spa
  • Flexion Therapeutics, Inc.
  • GlaxoSmithKline PLC
  • Hanmi Pharm. Co., Ltd.
  • Horizon Therapeutics PLC
  • Kitov Pharmaceuticals Ltd.
Product Code: MRR-DD6333AE50BA

The Osteoarthritis Therapeutics Market was valued at USD 7.90 billion in 2023, expected to reach USD 8.69 billion in 2024, and is projected to grow at a CAGR of 10.39%, to USD 15.78 billion by 2030.

Osteoarthritis therapeutics refer to a wide array of treatments designed to alleviate the symptoms and slow the progression of osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage. The scope includes but is not limited to pharmaceuticals like NSAIDs, corticosteroids, and analgesics, biologics, and emerging therapies such as gene therapy and stem cell treatment. The necessity for these therapeutics arises from the growing prevalence of osteoarthritis worldwide, driven by an aging population, increased obesity rates, and lifestyle changes. These therapeutics find application in reducing pain, inflammation, and improving joint function, primarily targeting affected individuals for use at clinics, hospitals, and home healthcare settings. Market growth is influenced by technological advancements, increasing R&D investments, and a rising awareness of early rehabilitation. Furthermore, the development of combination therapies and minimally invasive procedures present significant opportunities. Companies can capitalize by investing in innovative technologies and expanding their product portfolios through strategic partnerships and acquisitions. However, high treatment costs, stringent regulatory requirements, and potential side effects present limitations to market expansion. Innovation and research should focus on developing cost-effective, patient-friendly, and targeted treatment options with reduced side effects. Leveraging AI and machine learning for drug discovery and developing personalized medicine tailored to individual patient profiles could offer competitive advantages. The osteoarthritis therapeutics market is dynamic, characterized by rapid advancements and a competitive landscape necessitating constant adaptation. Companies investing in advanced research to understand the disease mechanisms and improve delivery systems will likely thrive. While promising, the market requires navigating regulatory challenges and ensuring affordability to reach a broader patient base, underscoring the need for collaboration with government bodies and healthcare institutions to facilitate widespread access and education on osteoarthritis management.

KEY MARKET STATISTICS
Base Year [2023] USD 7.90 billion
Estimated Year [2024] USD 8.69 billion
Forecast Year [2030] USD 15.78 billion
CAGR (%) 10.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Osteoarthritis Therapeutics Market

The Osteoarthritis Therapeutics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of osteoarthritis across the globe
    • Potential demand for minimally invasive surgical procedures
    • Growing geriatric population coupled with increasing sports injury worldwide
  • Market Restraints
    • Concern associated with adverse effects of NSAID
  • Market Opportunities
    • Emerging pharmaceuticals therapies for osteoarthritis
    • Ongoing research and development in the osteoarthritis field
    • Increasing governments supports towards the osteoarthritis treatment
    • Rising healthcare expenditure per capita income in the emerging economies
  • Market Challenges
    • Rapid adoption of non-drug pain management therapies

Porter's Five Forces: A Strategic Tool for Navigating the Osteoarthritis Therapeutics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Osteoarthritis Therapeutics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Osteoarthritis Therapeutics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Osteoarthritis Therapeutics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Osteoarthritis Therapeutics Market

A detailed market share analysis in the Osteoarthritis Therapeutics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Osteoarthritis Therapeutics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Osteoarthritis Therapeutics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Osteoarthritis Therapeutics Market

A strategic analysis of the Osteoarthritis Therapeutics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Osteoarthritis Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Almatica Pharma LLC, Anika Therapeutics, Inc., Assertio Therapeutics, Inc., Atnahs Pharma UK Limited, Bayer AG, Bioventus, Eli Lilly and Company, Ferring B.V., Fidia Farmaceutici s.p.a., Flexion Therapeutics, Inc., GlaxoSmithKline PLC, Hanmi Pharm. Co., Ltd., Horizon Therapeutics PLC, and Kitov Pharmaceuticals Ltd..

Market Segmentation & Coverage

This research report categorizes the Osteoarthritis Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Anatomy, market is studied across Hand Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, and Small Joint Osteoarthritis.
  • Based on Drug Type, market is studied across Analgesics, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs, and Viscosupplementation Agents. The Analgesics is further studied across Acetaminophen and Duloxetine. The Nonsteroidal Anti-inflammatory Drugs is further studied across Aspirin, Diclofenac, Ibuprofen, and Naproxen.
  • Based on Route of Administration, market is studied across Oral Route, Parenteral Route, and Topical Route.
  • Based on Purchasing Pattern, market is studied across Over-the-Counter Drugs and Prescription Drugs.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of osteoarthritis across the globe
      • 5.1.1.2. Potential demand for minimally invasive surgical procedures
      • 5.1.1.3. Growing geriatric population coupled with increasing sports injury worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Concern associated with adverse effects of NSAID
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging pharmaceuticals therapies for osteoarthritis
      • 5.1.3.2. Ongoing research and development in the osteoarthritis field
      • 5.1.3.3. Increasing governments supports towards the osteoarthritis treatment
      • 5.1.3.4. Rising healthcare expenditure per capita income in the emerging economies
    • 5.1.4. Challenges
      • 5.1.4.1. Rapid adoption of non-drug pain management therapies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Osteoarthritis Therapeutics Market, by Anatomy

  • 6.1. Introduction
  • 6.2. Hand Osteoarthritis
  • 6.3. Hip Osteoarthritis
  • 6.4. Knee Osteoarthritis
  • 6.5. Small Joint Osteoarthritis

7. Osteoarthritis Therapeutics Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Analgesics
    • 7.2.1. Acetaminophen
    • 7.2.2. Duloxetine
  • 7.3. Corticosteroids
  • 7.4. Nonsteroidal Anti-inflammatory Drugs
    • 7.4.1. Aspirin
    • 7.4.2. Diclofenac
    • 7.4.3. Ibuprofen
    • 7.4.4. Naproxen
  • 7.5. Viscosupplementation Agents

8. Osteoarthritis Therapeutics Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral Route
  • 8.3. Parenteral Route
  • 8.4. Topical Route

9. Osteoarthritis Therapeutics Market, by Purchasing Pattern

  • 9.1. Introduction
  • 9.2. Over-the-Counter Drugs
  • 9.3. Prescription Drugs

10. Osteoarthritis Therapeutics Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies

11. Americas Osteoarthritis Therapeutics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Osteoarthritis Therapeutics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Osteoarthritis Therapeutics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Almatica Pharma LLC
  • 3. Anika Therapeutics, Inc.
  • 4. Assertio Therapeutics, Inc.
  • 5. Atnahs Pharma UK Limited
  • 6. Bayer AG
  • 7. Bioventus
  • 8. Eli Lilly and Company
  • 9. Ferring B.V.
  • 10. Fidia Farmaceutici s.p.a.
  • 11. Flexion Therapeutics, Inc.
  • 12. GlaxoSmithKline PLC
  • 13. Hanmi Pharm. Co., Ltd.
  • 14. Horizon Therapeutics PLC
  • 15. Kitov Pharmaceuticals Ltd.

LIST OF FIGURES

  • FIGURE 1. OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. OSTEOARTHRITIS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. OSTEOARTHRITIS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OSTEOARTHRITIS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OSTEOARTHRITIS THERAPEUTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SMALL JOINT OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ACETAMINOPHEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DULOXETINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ASPIRIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY VISCOSUPPLEMENTATION AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ORAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PARENTERAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TOPICAL ROUTE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OVER-THE-COUNTER DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANATOMY, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANALGESICS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PURCHASING PATTERN, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ANA